FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/02/2025
Voltar para busca
Dado oficial do USPTO
LYSOSEEKER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
19/01/2023
Data de registro
13/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/08/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
DE
Examinador
COHEN, ROBERT ANDREW
Unidade examinadora
L30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
S. T. (pessoa física)
Representantes
Claudia W. Stangle Leydig, Voit & Mayer Ltd.
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological research in the field of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; Pharmaceutical products development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; database services, namely, electronic storage of data in computer databases; design, engineering, research, development and testing services in the field of pharmaceuticals, biotechnology, biology, biomedicine, genetics, molecular sciences, therapeutics, chemistry and biochemistry for medical, scientific, and technological applications; preparation of scientific analysis and evaluations namely, testing of pharmaceuticals and pharmaceutical product evaluation; consultancy relating to research and development in the field of therapeutics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; medical laboratory services
Classe 44
Medical services, medical diagnostic testing services; medical and pharmaceutical consultancy; medical analysis services relating to the diagnosis and treatment of persons; laboratory analysis services relating to the diagnosis and treatment of persons in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical examinations; medical screening; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases;medical analysis services relating to the treatment of patients for diagnosising and treating illnessnes
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2025
FIMP
FINAL DISPOSITION PROCESSED
03/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
13/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2024
PUBO
PUBLISHED FOR OPPOSITION
28/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
18/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
18/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2024
RFNT
REFUSAL PROCESSED BY IB
22/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/10/2023
RFRR
REFUSAL PROCESSED BY MPU
30/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/10/2023
CNRT
NON-FINAL ACTION WRITTEN
25/10/2023
DOCK
ASSIGNED TO EXAMINER
17/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LYSOSEEKER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.